AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 268: R723-R730, 1995;
0363-6119/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapusta, D. R.
Right arrow Articles by Obih, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapusta, D. R.
Right arrow Articles by Obih, J. C.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 3 723-R730, Copyright © 1995 by American Physiological Society

ARTICLES

Role of endogenous central opioid mechanisms in maintenance of body sodium balance

D. R. Kapusta and J. C. Obih
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, New Orleans 70112.

The role of endogenous central opioids in the regulation of renal function was studied in Sprague-Dawley rats. In metabolism studies, changes in sodium balance were examined during normal dietary sodium intake (days 1-7; Na+ of 174 meq/kg) and sodium restriction (days 8-14; Na+ of 4.0 meq/kg). The influence of endogenous central opioids was investigated by repeating the protocol in the same rats during intracerebroventricular infusion of the opioid antagonist naltrexone methylbromide (NMBR). Intracerebroventricular NMBR did not alter sodium balance in rats fed normal sodium chow. In contrast, on low-sodium days 8 and 9, rats exhibited a more negative sodium balance during intracerebroventricular NMBR (day 8; -1,191 +/- 37 mu eq) compared with respective predrug control levels (day 8; -641 +/- 39 mu eq). Subcutaneous NMBR did not alter renal adaptation to sodium restriction. Thus central opioids are not involved in the maintenance of sodium balance during normal sodium intake. However, when dietary sodium is restricted, central opioid pathways are activated as a mechanism to maximally retain sodium.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Burmeister, M. A. Ansonoff, J. E. Pintar, and D. R. Kapusta
Nociceptin/Orphanin FQ (N/OFQ)-Evoked Bradycardia, Hypotension, and Diuresis Are Absent in N/OFQ Peptide (NOP) Receptor Knockout Mice
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. B. Gottlieb and D. R. Kapusta
Endogenous central {kappa}-opioid systems augment renal sympathetic nerve activity to maximally retain urinary sodium during hypotonic saline volume expansion
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1289 - R1296.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. F. Sezen, V. A. Kenigs, and D. R. Kapusta
Renal Excretory Responses Produced by the Delta Opioid Agonist, BW373U86, in Conscious Rats
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 238 - 245.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online